JB Chemicals & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2025 ,inter alia, to consider and approve (i) the audited ....
JBCHEPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
JB Chemicals & Pharmaceuticals has informed BSE that its Board of Directors will meet on May 14, 2025 to consider and approve the audited financial results for the quarter and financial year ended March 31, 2025. The Board will also consider and recommend a dividend on equity shares, if any, subject to shareholder approval. This is a routine pre-announcement under SEBI Listing Regulations and does not contain any actual financial numbers yet. Investors should wait for the results to be declared on or after May 14, 2025 to assess the company's FY25 performance.
No immediate impact on stock price from this filing alone, as it only confirms an upcoming board meeting. Investors should watch for the actual Q4 and FY25 results and dividend announcement on May 14, 2025, which could be a near-term catalyst depending on the numbers and dividend declared.